Authors:
FANTINI J
TAMALET T
HAMMACHE D
TOURRES C
DUCLOS N
YAHI N
Citation: J. Fantini et al., HIV-1-INDUCED PERTURBATIONS OF GLYCOSPHINGOLIPID METABOLISM ARE CELL-SPECIFIC AND CAN BE DETECTED AT EARLY STAGES OF HIV-1 INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 19(3), 1998, pp. 221-229
Authors:
TAMALET C
IZOPET J
KOCH N
FANTINI J
YAHI N
Citation: C. Tamalet et al., STABLE REARRANGEMENTS OF THE BETA-3-BETA-4 HAIRPIN LOOP OF HIV-1 REVERSE-TRANSCRIPTASE IN PLASMA VIRUSES FROM PATIENTS RECEIVING COMBINATION THERAPY, AIDS, 12(14), 1998, pp. 161-166
Authors:
HAMMACHE D
PIERONI G
YAHI N
DELEZAY O
KOCH N
LAFONT H
TAMALET C
FANTINI J
Citation: D. Hammache et al., SPECIFIC INTERACTION OF HIV-1 AND HIV-2 SURFACE ENVELOPE GLYCOPROTEINS WITH MONOLAYERS OF GALACTOSYLCERAMIDE AND GANGLIOSIDE GM3, The Journal of biological chemistry, 273(14), 1998, pp. 7967-7971
Authors:
HAMMACHE D
YAHI N
PIERONI G
ARIASI F
TAMALET C
FANTINI J
Citation: D. Hammache et al., SEQUENTIAL INTERACTION OF CD4 AND HIV-1 GP120 WITH A RECONSTITUTED MEMBRANE PATCH OF GANGLIOSIDE GM3 - IMPLICATIONS FOR THE ROLE OF GLYCOLIPIDS AS POTENTIAL HIV-1 FUSION COFACTORS, Biochemical and biophysical research communications, 246(1), 1998, pp. 117-122
Citation: S. Baghdiguian et J. Fantini, SURAMIN - A MOLECULE WITH A BROAD-SPECTRUM OF BIOLOGICAL AND THERAPEUTIC PROPERTIES, The Cancer journal, 10(1), 1997, pp. 31-37
Authors:
TAMALET C
LAFEUILLADE A
FANTINI J
POGGI C
YAHI N
Citation: C. Tamalet et al., QUANTIFICATION OF HIV-1 VIRAL LOAD IN LYMPHOID AND BLOOD-CELLS ASSESSMENT DURING 4-DRUG COMBINATION THERAPY, AIDS, 11(7), 1997, pp. 895-901
Citation: Nw. Lutz et al., PERTURBATIONS OF GLUCOSE-METABOLISM ASSOCIATED WITH HIV-INFECTION IN HUMAN INTESTINAL EPITHELIAL-CELLS - A MULTINUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY STUDY, AIDS, 11(2), 1997, pp. 147-155
Authors:
DELEZAY O
KOCH N
YAHI N
HAMMACHE D
TOURRES C
TAMALET C
FANTINI J
Citation: O. Delezay et al., COEXPRESSION OF CXCR4 FUSIN AND GALACTOSYLCERAMIDE IN THE HUMAN INTESTINAL EPITHELIAL-CELL LINE HT-29/, AIDS, 11(11), 1997, pp. 1311-1318
Authors:
DELEZAY O
YAHI N
TAMALET C
BAGHDIGUIAN S
BOUDIER JA
FANTINI J
Citation: O. Delezay et al., DIRECT EFFECT OF TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-I) ON INTESTINAL EPITHELIAL-CELL DIFFERENTIATION - RELATIONSHIP TO HIV-I ENTEROPATHY, Virology, 238(2), 1997, pp. 231-242
Authors:
FANTINI J
HAMMACHE D
DELEZAY O
YAHI N
ANDREBARRES C
RICOLATTES I
LATTES A
Citation: J. Fantini et al., SYNTHETIC SOLUBLE ANALOGS OF GALACTOSYLCERAMIDE (GALCER) BIND TO THE V3 DOMAIN OF HIV-1 GP120 AND INHIBIT HIV-1-INDUCED FUSION AND ENTRY, The Journal of biological chemistry, 272(11), 1997, pp. 7245-7252
Authors:
FANTINI J
FOURNIER D
BOCCARA AC
PLICHON V
Citation: J. Fantini et al., MICROFLUX DETECTION AT THE SOLID-LIQUID INTERFACE WITH AN INTERFEROMETRIC MICROSCOPE, Electrochimica acta, 42(6), 1997, pp. 937-944
Authors:
BAGHDIGUIAN S
BOUDIER JL
BOUDIER JA
FANTINI J
Citation: S. Baghdiguian et al., INTRACELLULAR-LOCALIZATION OF SURAMIN, AN ANTICANCER DRUG, IN HUMAN COLON ADENOCARCINOMA CELLS - A STUDY BY QUANTITATIVE AUTORADIOGRAPHY, European journal of cancer, 32A(3), 1996, pp. 525-532
Citation: S. Baghdiguian et al., MORPHOLOGICAL ALTERATIONS ASSOCIATED WITH HIV-INFECTION OF CD4(-) GALCER(+) HUMAN INTESTINAL EPITHELIAL-CELLS/, Perspectives in drug discovery and design, 5, 1996, pp. 73-82
Authors:
YAHI N
RATNER L
HAROUSE JM
GONZALEZSCARANO F
FANTINI J
Citation: N. Yahi et al., GENETIC-DETERMINANTS CONTROLLING HIV-1 TROPISM FOR CD4(-) GALCER(+) HUMAN INTESTINAL EPITHELIAL-CELLS/, Perspectives in drug discovery and design, 5, 1996, pp. 161-168
Authors:
DAYANITHI G
YAHI N
BAGHDIGUIAN S
FANTINI J
Citation: G. Dayanithi et al., GALACTOSYLCERAMIDE AND TRANSMEMBRANE SIGNALING IN ENTEROCYTES - CALCIUM RESPONSE INDUCED BY HIV-1 SURFACE-ENVELOPE GLYCOPROTEIN GP120, Perspectives in drug discovery and design, 5, 1996, pp. 181-191
Citation: O. Delezay et al., DETECTION OF FUNCTIONAL GALACTOSYLCERAMIDE (GALCER) RECEPTORS ON CD4-NEGATIVE HIV-1 TARGET-CELLS, Perspectives in drug discovery and design, 5, 1996, pp. 192-202
Citation: D. Hammache et al., SURAMIN - A POLYSULFONATED COMPOUND THAT INHIBITS THE BINDING OF HIV-1 GP120 TO GALCER SULFATIDE AND BLOCKS THE CD4-INDEPENDENT PATHWAY OF HIV-1 INFECTION IN MUCOSAL EPITHELIAL-CELLS/, Perspectives in drug discovery and design, 5, 1996, pp. 225-233
Authors:
FANTINI J
YAHI N
MABROUK K
ROCHAT H
VANRIETSCHOTEN J
SABATIER JM
Citation: J. Fantini et al., V3 LOOP-DERIVED MULTIBRANCHED PEPTIDES AS INHIBITORS OF HIV-INFECTIONIN CD4(-) CELLS() AND CD4(), Perspectives in drug discovery and design, 5, 1996, pp. 243-250
Citation: Nw. Lutz et al., ANALYSIS OF INDIVIDUAL PURINE AND PYRIMIDINE NUCLEOSIDE DIPHOSPHATE AND TRIPHOSPHATE AND OTHER CELLULAR METABOLITES IN PCA EXTRACTS BY USING MULTINUCLEAR HIGH-RESOLUTION NMR-SPECTROSCOPY, Magnetic resonance in medicine, 36(5), 1996, pp. 788-795
Authors:
BAGHDIGUIAN S
BOUDIER JA
BOUDIER JL
FANTINI J
Citation: S. Baghdiguian et al., COLOCALIZATION OF SURAMIN AND SERUM-ALBUMIN IN LYSOSOMES OF SURAMIN-TREATED HUMAN COLON-CANCER CELLS, Cancer letters, 101(2), 1996, pp. 179-184
Citation: Nw. Lutz et al., NEW METHOD FOR THE DETERMINATION OF SPECIFIC C-13 ENRICHMENT IN PHOSPHORYLATED [1-C-13]GLUCOSE METABOLITES C-13-COUPIED, H-1-DECOUPLED P-31-NMR SPECTROSCOPY OF TISSUE PERCHLORIC-ACID EXTRACTS, European journal of biochemistry, 238(2), 1996, pp. 470-475
Citation: O. Delezay et al., SPC3, A V3 LOOP-DERIVED SYNTHETIC PEPTIDE INHIBITOR OF HIV-1 INFECTION, BINDS TO CELL-SURFACE GLYCOSPHINGOLIPIDS, Biochemistry, 35(49), 1996, pp. 15663-15671